Dr. Randy Kahn

Randy Kahn, M.D., is board certified in internal medicine and radiation oncology. A graduate of Franklin and Marshall College in Pennsylvania, he received his medical degree from New York University School of Medicine in 1984.

Dr. Kahn completed residency programs in Internal Medicine at the University of Miami’s Jackson Memorial Hospital in 1985 and at NYU’s Bellevue Hospital in 1987. He then completed his residency in Radiation Oncology at Columbia-Presbyterian Medical Center in New York in 1990, where he served as Chief Resident.

Dr. Kahn’s affiliations include Brandon Hospital, South Bay Hospital, Town & Country Hospital, South Florida Baptist Hospital, Tampa General Hospital and Memorial Hospital. He has special expertise in Intensity Modulated Radiotherapy (IMRT), prostate brachytherapy, and stereotactic radiosurgery.

Dr. Kahn is a member of the American Society for Therapeutic Radiation and Oncology and the American College of Radiation Oncology.

Dr. Kahn has been practicing in the Tampa Bay area since 1990 and is associated with Tampa Bay Radiation Oncology, with offices in Brandon, Sun City Center, and Tampa, Florida.

CyberKnife Cancer Care

The CyberKnife Centers of Tampa Bay are outpatient cancer treatment facilities dedicated to providing image-guided radiosurgery using the CyberKnife System. CyberKnife offers new hope for the treatment of tumors and lesions - including brain cancer, head and neck cancer, liver cancer, lung cancer, metastases, cancer of the pancreas, prostate cancer, and spinal tumors.

Accurate Cancer Treatment

CyberKnife can treat benign tumors and many types of cancer, including, brain, head and neck, liver, lung, pancreatic, and prostate cancer, metastases, and spinal tumors.

Robotic Cancer Surgery

The CyberKnife System uses image-guided robotics to precisely destroy cancer tumors and other lesions. This precision spares normal, healthy tissue, while the higher dosage offers improved chances for cure from cancer. The CyberKnife can treat inoperable and hard to reach cancerous tumors.

We Accept Most Insurance Carriers



We work to obtain pre-authorization with all insurance companies.